Lilly Insulin - Search News

Weight-loss drug Mounjaro launched in India

Reuters on MSN · 14h

Eli Lilly launches weight-loss drug Mounjaro in India, beats Novo Nordisk to major market

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk for a much-awaited entry into the world's most populous country grappling with increasing rates of obesity and diabetes.

Times Now on MSN · 3h

Eli-Lilly Launched Its Much Talked About Weight-loss Drug Mounjaro in India! Does It Have Any Side-effects?

Popular anti-diabetes and obesity drug Mounjaro has been launched in India in a single-dose vial. While it has already been in strong demand in the US and Europe, the India launch is part of pharmaceutical giant Eli Lilly’s broader strategy to expand access to innovative treatments in emerging markets.

Patrika News · 1h

Mounjaro, Diabetes and Weight-Loss Drug, Launched in India

American pharmaceutical company Eli Lilly has launched its drug, Mounjaro, in India. Mounjaro is administered as a once-weekly injection. | Weight Loss News | Health News | Patrika News

2d

Is Eli Lilly and Company (LLY) the Best Diabetes Stock to Buy According to Billionaires?

We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...

16hon MSN

Mounjaro hits shelves in India: How Eli Lilly's anti-diabetes drug compares with Ozempic — price, side effects and more

Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results